|
Suzanne Tepper, PharmD, RPh
Vice President, Pharmacovigilance Practice
Dr. Tepper has extensive experience in pharmacovigilance processes and drug safety systems. She joined Sentrx in March 2006 and leads the Safety Monitors in the intake and investigation of adverse events, ensuring client and regulatory commitments are met.
Prior to Sentrx, held management positions at Aventis, formerly Hoechst Marion Roussel, in their Global Pharmacovigilance and Epidemiology group. There she led multi-disciplined teams to successfully complete several important projects, including the safety data migration associated with the merger that created Aventis; the conversion to the Medical Dictionary for Regulatory Affairs (MedDRA); and implementation of the electronic submission of Individual Case Safety Reports (ICSRs) to the FDA. Tepper also held positions at Johnson & Johnson in their Benefit Risk Management group and in Global Pharmacovigilance at Schering-Plough Research Institute, improving regulatory reporting and signal detection programs.
Prior to entering the pharmaceutical industry, Dr. Tepper owned a retail pharmacy for nearly ten years and also worked in the hospital pharmacy setting. She is a registered pharmacist and holds a Doctorate of Pharmacy, a Bachelor of Science in Pharmacy, and a Bachelor of Arts in Special Education. |
